IL146917A0 - Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid - Google Patents
Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acidInfo
- Publication number
- IL146917A0 IL146917A0 IL14691700A IL14691700A IL146917A0 IL 146917 A0 IL146917 A0 IL 146917A0 IL 14691700 A IL14691700 A IL 14691700A IL 14691700 A IL14691700 A IL 14691700A IL 146917 A0 IL146917 A0 IL 146917A0
- Authority
- IL
- Israel
- Prior art keywords
- antagonist
- ethylenediamine tetraacetic
- acid
- composition containing
- boric acid
- Prior art date
Links
- 229940123413 Angiotensin II antagonist Drugs 0.000 title abstract 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002333 angiotensin II receptor antagonist Substances 0.000 title abstract 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004327 boric acid Substances 0.000 title abstract 2
- 238000011200 topical administration Methods 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16494599 | 1999-06-11 | ||
| PCT/JP2000/003779 WO2000076543A1 (fr) | 1999-06-11 | 2000-06-09 | Composition permettant de reduire la tension oculaire et destinee a l'administration topique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL146917A0 true IL146917A0 (en) | 2002-08-14 |
Family
ID=15802847
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14691700A IL146917A0 (en) | 1999-06-11 | 2000-06-09 | Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid |
| IL146917A IL146917A (en) | 1999-06-11 | 2001-12-04 | Preparation containing angiotensin II antagonist, boric acid and ethylindiamine tetraacitic acid |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL146917A IL146917A (en) | 1999-06-11 | 2001-12-04 | Preparation containing angiotensin II antagonist, boric acid and ethylindiamine tetraacitic acid |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6777436B2 (cs) |
| EP (1) | EP1186302B1 (cs) |
| KR (1) | KR100611543B1 (cs) |
| CN (1) | CN1198650C (cs) |
| AT (1) | ATE295721T1 (cs) |
| AU (1) | AU759513B2 (cs) |
| BR (1) | BR0011477A (cs) |
| CA (1) | CA2376780C (cs) |
| CZ (1) | CZ300553B6 (cs) |
| DE (1) | DE60020230T2 (cs) |
| ES (1) | ES2242619T3 (cs) |
| HU (1) | HUP0201466A3 (cs) |
| IL (2) | IL146917A0 (cs) |
| MX (1) | MXPA01012752A (cs) |
| NO (1) | NO328211B1 (cs) |
| NZ (1) | NZ516033A (cs) |
| PL (1) | PL200009B1 (cs) |
| PT (1) | PT1186302E (cs) |
| RU (1) | RU2227740C2 (cs) |
| TR (1) | TR200103603T2 (cs) |
| TW (1) | TWI245639B (cs) |
| WO (1) | WO2000076543A1 (cs) |
| ZA (1) | ZA200109943B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4000505B2 (ja) * | 1999-12-01 | 2007-10-31 | 第一三共株式会社 | 緑内障を治療するための併用剤 |
| TW200304812A (en) * | 2002-03-08 | 2003-10-16 | Sankyo Co | An eye drop containing a tetrazole derivative |
| US20050119299A1 (en) * | 2002-03-08 | 2005-06-02 | Sankyo Company, Limited | Ophthalmic solutions containing tetrazole derivatives |
| CN101163474B (zh) * | 2005-04-21 | 2012-02-22 | 参天制药株式会社 | 角膜结膜病变治疗剂 |
| EP2684574B1 (en) * | 2007-11-30 | 2016-07-27 | Toltec Pharmaceuticals, Llc | Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991015206A1 (en) * | 1990-04-05 | 1991-10-17 | E.I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists |
| TW200402B (cs) * | 1990-08-13 | 1993-02-21 | Senju Pharma Co | |
| RU2007152C1 (ru) * | 1992-10-01 | 1994-02-15 | Курский Государственный Медицинский Институт | Офтальмологическое средство и способ его получения |
| CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
| JPH09508641A (ja) * | 1994-02-08 | 1997-09-02 | チバーガイギー アクチエンゲゼルシャフト | アンギオテンシン▲ｉｉ▼拮抗薬による正常眼圧緑内障の治療 |
| ES2163501T3 (es) | 1994-03-16 | 2002-02-01 | Sankyo Co | Agente para la disminucion de la tension ocular. |
| JPH07324034A (ja) * | 1994-05-30 | 1995-12-12 | Toa Yakuhin Kk | フマル酸ケトチフェン含有の点眼剤 |
-
2000
- 2000-06-09 RU RU2001133273/15A patent/RU2227740C2/ru not_active IP Right Cessation
- 2000-06-09 CN CNB008113513A patent/CN1198650C/zh not_active Expired - Fee Related
- 2000-06-09 HU HU0201466A patent/HUP0201466A3/hu unknown
- 2000-06-09 ES ES00935630T patent/ES2242619T3/es not_active Expired - Lifetime
- 2000-06-09 BR BR0011477-4A patent/BR0011477A/pt not_active Application Discontinuation
- 2000-06-09 MX MXPA01012752A patent/MXPA01012752A/es active IP Right Grant
- 2000-06-09 WO PCT/JP2000/003779 patent/WO2000076543A1/ja not_active Application Discontinuation
- 2000-06-09 CA CA002376780A patent/CA2376780C/en not_active Expired - Fee Related
- 2000-06-09 CZ CZ20014415A patent/CZ300553B6/cs not_active IP Right Cessation
- 2000-06-09 DE DE60020230T patent/DE60020230T2/de not_active Expired - Lifetime
- 2000-06-09 TR TR2001/03603T patent/TR200103603T2/xx unknown
- 2000-06-09 PT PT00935630T patent/PT1186302E/pt unknown
- 2000-06-09 KR KR1020017015901A patent/KR100611543B1/ko not_active Expired - Fee Related
- 2000-06-09 EP EP00935630A patent/EP1186302B1/en not_active Expired - Lifetime
- 2000-06-09 AU AU51086/00A patent/AU759513B2/en not_active Ceased
- 2000-06-09 AT AT00935630T patent/ATE295721T1/de not_active IP Right Cessation
- 2000-06-09 NZ NZ516033A patent/NZ516033A/en not_active IP Right Cessation
- 2000-06-09 PL PL352161A patent/PL200009B1/pl not_active IP Right Cessation
- 2000-06-09 TW TW089111297A patent/TWI245639B/zh not_active IP Right Cessation
- 2000-06-09 IL IL14691700A patent/IL146917A0/xx active IP Right Grant
-
2001
- 2001-12-03 ZA ZA200109943A patent/ZA200109943B/en unknown
- 2001-12-04 IL IL146917A patent/IL146917A/en not_active IP Right Cessation
- 2001-12-10 US US10/016,535 patent/US6777436B2/en not_active Expired - Fee Related
- 2001-12-10 NO NO20016023A patent/NO328211B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7833698A (en) | Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use | |
| AU2467297A (en) | New benzimidazole derivatives with antihistaminic activity | |
| EP1193270A3 (en) | Pyrrolobenzodiazepines | |
| AU5557800A (en) | Thieno- and furopyrimidine derivatives as a2a-receptor antagonists | |
| MY129973A (en) | Sulphonylbenzyl-substituted pyridones. | |
| CA2198535A1 (en) | Method of increasing testosterone | |
| AU2001269688A1 (en) | Combination containing an antifolate and methylmalonic acid lowering agent | |
| AU2417892A (en) | Battery saver for wireless telephone | |
| AU2859700A (en) | Overhead storage device | |
| AU5614199A (en) | Needle injection-facilitating device | |
| AU6440600A (en) | Combination of active agents, said combination containing clonidine | |
| AU4301596A (en) | Transdermal preparation containing a loratidine metabolite with antihistaminic activity | |
| IL146917A0 (en) | Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid | |
| IE831517L (en) | Pesticidal 1-(alkyl-phenoxyaryl)-benzoyl ureas. | |
| FR2797887B1 (fr) | Dispositif emboitable a usage biologique, notamment pour la culture cellulaire | |
| AU674379B2 (en) | Antitussive | |
| SG71756A1 (en) | Tape carrier package | |
| AU7887300A (en) | Buffered phosphorus containing solution | |
| EP0948961A3 (de) | Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff | |
| EP0667158A4 (en) | TROMBOZYTE AGGREGATION INHIBITORS. | |
| AU7402598A (en) | Guinidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists | |
| AU9531898A (en) | Process for preparing 2-halogenated indan-1-ones | |
| AU6628296A (en) | Active disk guide | |
| TW356416B (en) | Stabilized agrochemical composition containing 1-(2-chloroimidazolo[1,2-a]pyrid-3-ylsulfonyl)-3-[4,6-dimethylpyrimid-2-yl]urea or its salts | |
| ES2116399T3 (es) | Derivados tiazolicos de alcoxiacrilatos con una actividad fungicida. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |